Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

被引：0
|
作者：
A Gaedigk
A Bhathena
L Ndjountché
R E Pearce
S M Abdel-Rahman
S W Alander
L DiAnne Bradford
J Steven Leeder
机构：
来源：
The Pharmacogenomics Journal | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: The Pharmacogenomics Journal (2005) 5, 173–182. doi:10.1038/sj.tpj.6500305 The authors wish to add an additional co-author as indicated in bold: A Gaedigk, A Bhathena, L Ndjountché, RE Pearce, SM Abdel-Rahman, SW Alander, L DiAnne Bradford, PK Rogan3 and J Steven Leeder With the following affiliation: 3 Laboratory of Human Molecular Genetics, Children's Mercy Hospital & Clinics, Kansas City, MO, USA.
引用
收藏
页码：276 / 276
相关论文
共 50 条
  • [21] Functional Characterization of Cytochrome P450 2D6 (CYP2D6) Allelic Variant CYP2D6*10
    Dong, A. N.
    Ong, C. E.
    Pan, Y.
    Palanisamy, U. D.
    Ismail, R.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 49 - 49
  • [22] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Independent commentary
    Brosen, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S749 - S750
  • [23] Effect of psychotropic medication on the cytochrome P4502D6 phenotype
    Hartler, S
    Kohler, D
    Fuchs, C
    Sieghart, W
    Hiemke, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 459 - 459
  • [24] Cytochrome P4502D6 polymorphism in eastern Indian population
    Dhuya, Monalisa
    Pal, Murari Mohan
    Hazra, Avijit
    Chatterjee, Suparna
    Gogtay, Nithya
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (03) : 189 - 195
  • [25] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Author's commentary
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S748 - S749
  • [26] A patient with treatment-resistant schizophrenia and cytochrome P4502D6 gene duplication
    Kawanishi, C
    Furuno, T
    Kishida, I
    Matsumura, T
    Kosaka, K
    CLINICAL GENETICS, 2002, 61 (02) : 152 - 154
  • [27] Polymorphism in cytochrome P4502D6 mediated activation of aldicarb in rats
    Silvari, V
    D'Angelo, V
    Catania, S
    Tornqvist, M
    Zahlsen, K
    Costa, C
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 256 - 257
  • [28] Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 17 - 22
  • [29] Extension of a predictive substrate model for human cytochrome P4502D6
    DeGroot, MJ
    Bijloo, GJ
    VanAcker, FAA
    Guerra, CF
    Snijders, JG
    Vermeulen, NPE
    XENOBIOTICA, 1997, 27 (04) : 357 - 368
  • [30] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
12345